Browse Articles

Discover research articles across all indexed journals

Development and validation of a machine learning model to detect psychiatric symptoms in Huntington’s disease using speech analysis

PLoS ONE Quang Tuan Rémy Nguyen, Hadrien Titeux, Rachid Riad et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0350118

Huntington’s disease (HD) causes progressive disability through motor, psychiatric, and cognitive symptoms. Machine learning speech analysis can detect motor and cognitive symptoms of HD, but not yet psychiatric symptoms. This study investigated whether speech analyses can detect the presence of psychiatric symptoms in HD. Audio recordings of six narrative tasks (cookie-theft picture description, red-riding hood storytelling, most recent 24 hours recalling, happy, sad, or angry storytelling) were prospectively collected from subsequent genetically confirmed HD participants from the BIOHD and REPAIR CAPIT-HD-Beta cohorts at the Hospital Henri-Mondor, Créteil. Speech therapists blindly annotated speech samples to allow extraction of three types of features: linguistic, LASER, and acoustic features. Psychiatric symptoms in participants were detected using the Problem Behaviors Assessment Short version (PBA-s). Machine learning classifier models were trained on 80% of the 89 participants before being tested on the remaining 20% of individuals. F1-scores were calculated and compared to chance. Linguistic features detected obsessive/compulsive behavior (OCB) with all but joy task, and best with the cookie task (F1-score: 0.67, confidence interval [0.47–0.86] (p ≦ 0.001)). They also best detected depression with the red-riding hood (F1 score 0.66, [0.45–0.87], p ≦ 0.001), apathy with the joy task (0.60, [0.39–0.81], p ≦ 0.001), but not irritability. LASER features best detected OCB (0.65, [0.45–0.84], p ≦ 0.001), depression (0.60, [0.40, 0.80], p ≦ 0.01) and apathy (0.61, [0.37, 0.86], p ≦ 0.001) from the red-riding hood task, but not irritability. Acoustic features best detected depression (0.63, [0.46, 0.80], p ≦ 0.001) and OCB (0.60, [0.43, 0.77], p ≦ 0.001) but not apathy nor irritability. This study showed that speech analyses can detect obsessive/compulsive behaviors, depression, and apathy in HD participants but not irritability. Linguistic and LASER features provided the most consistent detections, but acoustic features also detected depression and OCB, highlighting their complementary role for psychiatric characterization in HD.

Tuning the Disordered Structure: Recent Advances in Amorphization Engineering for Enhanced Photocatalysis

Advanced Materials Sijie Wan, Yaqian Lan, Shaowen Cao Jul 01, 2026 DOI: 10.1002/adma.73672

ABSTRACT Amorphization engineering, which introduces tunable structural disorder into crystalline photocatalysts, has emerged as a promising strategy for enhancing photocatalytic performance. The disorder‐induced increase in system entropy can lead to a “cocktail effect”, manifesting as a reconstruction of electronic structures, asymmetric electron density distribution, tailored relaxation dynamics of photoinduced charge carriers, unique local microenvironments of active sites, etc. These features collectively influence the overall photocatalytic process. Herein, this perspective presents recent advances in amorphization engineering, covering the synthesis, modification, and application of amorphous‐based photocatalysts. The synthesis section elaborates on preparation methodologies, while the modification and application sections systematically summarize various amorphization schemes for performance enhancement. Despite the progress, challenges remain in achieving controllable synthesis and elucidating the structure‐activity relationship. Future efforts should focus on gaining mechanistic insights and developing advanced characterization techniques to guide the rational design of high‐performance amorphous‐based photocatalysts for sustainable energy and environmental applications.

Microglia maintain retinal redox homeostasis following ablation of rod photoreceptors in zebrafish

Journal of Biological Chemistry Michael Morales, Diana M. Mitchell Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113169

A novel oncolytic vaccinia virus armed with IL-21 and 4-1BBL for intravesical treatment of NMIBC: Preclinical efficacy and first-in-human safety evaluation.

Journal of Clinical Oncology Shun Zhang, Hailong Liu, Ding Xu et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.198

198 Background: Oncolytic viruses are emerging cancer immunotherapies. For non–muscle-invasive bladder cancer (NMIBC), intravesical delivery allows high local exposure with limited systemic toxicity. This study was conducted to evaluate anti-tumor efficacy, mechanism, and safety of KM1, a novel developed oncolytic vaccinia virus modified with tyrosine kinase deletion, L025 and A46R gene deletion, and armed with interleukin 21 and 4-1BBL in murine models and humans. Methods: In vitro assays assessed virus replication, cytotoxicity, and transgene expression in human and murine bladder cancer cell lines and organoids. In vivo studies assessed immune activation, toxicity, and antitumor efficacy in murine subcutaneous and orthotopic bladder tumor models. An investigator-initiated phase 1a trial enrolled NMIBC patients who had failed prior BCG therapy or declined further BCG. This multicenter, single-arm study used 3+3 dose-escalation with primary endpoints of safety and tolerability (AE and DLTs). Planned dose levels were 2×10^9 PFU (DL1), 5×10^9 PFU (DL2), and 1×10^10 PFU (DL3) per instillation. Following completion of DL1 and DL2, the protocol was amended to discontinue further dose escalation (DL3 was not opened) and to enroll an expansion cohort at DL1 (additional n = 3) to further characterize safety/tolerability and PK/PD at the putative recommended dose. The induction regimen consisted of bladder irrigation with sucrose monolaurate, followed by intravesical KM1 retained for 2 hours, given twice weekly for 3 weeks and then once weekly for 3 weeks. Subsequent maintenance therapy comprised three intravesical KM1 instillations every 3 months. Results: KM1 selectively replicated in human and murine bladder cancer cells, induced high IL-21 and 4-1BBL secretion. Supernatant from KM1-infected cells activated CD8⁺ T cells and enhanced tumor-killing in vitro. In vivo, KM1 showed better antitumor efficacy than BCG, increased CD8⁺ T and NK cell infiltration and function. Depletion of either population diminished efficacy. In the phase 1a study, 12 patients received intravesical KM1 (DL1, n = 9 [including n = 3 expansion]; DL2, n = 3) and were evaluable. Ten TEAEs were reported, predominantly grade 1–2; the most common were noninfective cystitis (5/12, 41.7%) and urinary tract pain (4/12, 33.3%). One DL1 patient experienced a DLT of transient, likely treatment-related grade 3 liver injury that resolved within 1 week without sequelae. No KM1 DNA was detected in saliva, blood, or feces at any assessed time point. At a median follow-up of 10.1 months, all patients remained recurrence-free by 6 months (CR 12/12; 100%). Conclusions: KM1 showed selective replication, oncolysis, and immune activation in preclinical models. Early clinical data suggest favorable safety and promising antitumor activity of intravesical KM1 in NMIBC. Clinical trial information: ChiCTR2400086709 .

Mechanistic Characterization and Control of Branching in the Polymer of Intrinsic Microporosity PIM-1

Journal of the American Chemical Society Benjamin J. Pedretti, Andrea Giovanelli, Olivia J. Wilkinson et al. Jul 01, 2026 DOI: 10.1021/jacs.5c23293

A mathematical analysis of math anxiety dynamics using a classical SAS model: Bridging epidemic theory and pedagogical implications

PLoS ONE Shobha Islam, Dulali Iqbal, Mili Saha et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0351626

Students’ cognitive function and participation in mathematical problems are adversely affected by mathematics anxiety. This research develops and evaluates a dynamic mathematical model (SAS: Susceptible-Anxious-Susceptible) to investigate the evolution and transmission of math anxiety within students over time. The model divides students into two subgroups based on presence and absence of math anxiety. Using epidemiological modeling concepts, we derive the basic reproduction number R₀, which determines the conditions for persistence (R₀  >  1) or elimination (R₀  <  1) of anxiety. Our analysis proves that the anxiety-free equilibrium is both locally and globally asymptotically stable when R₀  <  1, while the anxiety-prevailing equilibrium is stable when R₀  >  1, with the system undergoing a transcritical bifurcation at R₀  =  1. Sensitivity analysis using Partial Rank Correlation Coefficient (PRCC) reveals that the university entrance rate (π) and social transmission rate (β) positively impact R₀, while recovery rate (α) and exit rate (μ) negatively influence it. Notably, π and μ are identified as the most influential parameters. Numerical simulations demonstrate that the population of students with mathematics anxiety is highly sensitive to changes in β and μ, while remaining relatively stable with fluctuations in π and α. These findings provide a quantitative framework for developing effective interventions, suggesting that reducing social transmission of anxiety and enhancing recovery through supportive mechanisms can significantly curb math anxiety prevalence in educational settings.

Engineering Layered Nanomaterials for Cancer Theranostics: Current Progress and Future Opportunities

Angewandte Chemie International Edition Xiangrong Pan, Tingting Hu, Yajie Zhang et al. Jul 01, 2026 DOI: 10.1002/anie.1634100

ABSTRACT Atomic‐level structural engineering represents a powerful paradigm for tailoring layered nanomaterials (LNs) toward advanced cancer theranostics, enabling precise control of physicochemical properties to overcome the limitations of conventional nanoplatforms. This review provides a comprehensive overview of the latest advances in engineering LNs, including layered metal oxides, layered double hydroxides, transition metal dichalcogenides, graphene, layered silicates, graphitic carbon nitride, metal carbides and nitrides, and other layered frameworks for cancer diagnosis and therapy. Five representative atomic‐level engineering strategies are discussed, including crystal phase engineering, defect engineering, heteroatom doping, interlayer spacing engineering, and crystalline‐to‐amorphous phase engineering. For each strategy, the underlying mechanisms, representative synthetic approaches, and their roles in optimizing theranostic performance, such as photothermal conversion, reactive oxygen species generation, and multimodal imaging, are critically discussed. Crucially, the advantages and inherent limitations of these engineering strategies are comparatively evaluated to provide a balanced perspective on their practical applicability. Finally, key challenges toward clinical translation, including structural stability, biosafety, and scalability, are highlighted. Future directions are proposed for developing intelligent, adaptive, and personalized LN‐based nanomedicines for precision oncology.

Decoupling‐Facilitated Mass‐Charge Transfer via Dual‐Interface Engineering for Efficient CO <sub>2</sub> Electrolysis

Advanced Materials Silong Dong, Yinyi Liu, Bohua Ren et al. Jul 01, 2026 DOI: 10.1002/adma.73692

ABSTRACT The gas‐electrolyte‐electrode triple‐phase interfaces (TPIs) critically govern the kinetics of the electrochemical CO 2 reduction reaction (CO 2 RR) by regulating concerted proton‐electron transfer processes. However, sluggish mass transfer and the unbalanced adsorption of key intermediates within the local microenvironment of TPI remain major obstacles to efficient multicarbon product formation. Here, we report a dual‐interface strategy featuring amphiphilic and biphasic architectures to decouple mass‐charge transfer, achieved through in‐situ electrochemical activation of a polydimethylsiloxane (PDMS)‐modified Cu‐BTC electrode. The hydrophilic/hydrophobic interface promotes the synergistic mass transfer of CO 2 and protons within the TPI microenvironment, whereas the amorphous/crystalline interface modulates the electronic structure of catalytic active sites to optimize the adsorption kinetics of key intermediates. Such decoupling‐mediation accelerated C 2 H 4 Faradaic efficiency (FE) exceeding 86% at ‐0.9 V (vs. reversible hydrogen electrode, RHE), over 2.5 times higher than that of the control groups. This work highlights the potential of dual‐interface decoupling engineering to simultaneously optimize CO 2 mass transport pathways and intermediate adsorption kinetics, thereby enabling highly efficient electrosynthesis of C 2 H 4 .

The DNTTIP1-PARP1 Interaction Orchestrates MiDAC Recruitment and Activity for NHEJ-Mediated Genome Stability

Journal of Biological Chemistry Yan Qin, Yanhui Ma, Ao Wei et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113342

Quantitative hazard visualization of radioisotope contamination risks in emergency settings following radium-223 therapy.

Journal of Clinical Oncology Soichi Makino, Kazunari Miyazawa, Koichi Morota et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.323

323 Background: Radium-223 (Ra-223), an alpha-emitting radiopharmaceutical, is a cornerstone of modern theranostics. While routine protocols are established, occupational contamination hazards during unexpected invasive procedures in emergency settings remain a critical regulatory blind spot. This study quantitatively assessed previously unrecognized radioisotope (RI) contamination risks using a deterministic hazard visualization model to identify systemic vulnerabilities. Methods: We analyzed an actual case of emergency surgery performed 21 days after Ra-223 administration to identify communication gaps. To assess hazards in time-critical scenarios, we developed a deterministic hazard visualization model to stress-test institutional preparedness. A worst-case scenario involved high-energy trauma occurring 1 hour post-administration with 2.0 L of hemorrhage. Contamination densities were calculated and compared with Japanese and US (10 CFR Part 835) regulatory thresholds. Results: In the actual case, external exposure was assessed via gamma-based dosimetry, leveraging Ra-223's ~1% gamma yield as a surrogate for alpha contamination; no measurable exposure was recorded. Model visualization indicated that in a massive hemorrhage scenario shortly after administration, initial surface contamination reached 77,220 dpm/100 cm²—386 times the US regulatory limit. Notably, even after ten simulated cleaning cycles, residual contamination remained irreducible to safe levels, staying 135 times higher than the limit. The model also highlighted potential radioactive release into public areas due to critical information gaps between facilities. Conclusions: Under the modeled conditions, contamination exceeded existing regulatory limits by substantial margins, rendering passive management insufficient. Protecting healthcare workers requires a paradigm shift toward autonomous safety management founded on proactive hazard visualization and integrated information-sharing. Establishing a knowledge-driven safety culture is indispensable to ensure robust protection in the rapidly evolving landscape of theranostics. Quantitative hazard visualization. Parameter Unit Value / Result Injected Activity (Ra-223, 70kg patient) MBq 3.85 Peak Activity Concentration in Blood (1 h) Bq/L 51,475 Assumed Blood Loss (Scenario 1: Trauma) L 1.0 Initial Surface Activity (Calculated) Bq 25,738 Initial Surface Contamination Density dpm/100 cm² 77,220 US Regulatory Limit (10 CFR 835) dpm/100 cm² 200 Model vs. US Limit Ratio (Initial) Ratio 386x Cleaning Simulation (10 Cycles, 10% Eff.) Ratio 0.35 Residual Contamination Density dpm/100 cm² 27,027 Model vs. US Limit Ratio (Residual) Ratio 135x

Correlated Atomic Vacancy Pairs Enable Electronic and Geometric Cooperation in Electrocatalysis

Journal of the American Chemical Society Cheng Chen, Ruonan Xiao, Xuan Liu et al. Jul 01, 2026 DOI: 10.1021/jacs.6c07115

Astrovirus in the Brazilian Amazon: First detection of non-classical astroviruses (MLB-3) in the Americas

PLoS ONE Dan Santos Alves, Dielle Monteiro Teixeira, Edivaldo Costa Sousa Junior et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352094

Human astrovirus (HAstV) is a viral agent responsible for acute gastroenteritis (AGE), primarily affecting children and the elderly worldwide. Belonging to the Astroviridae family, HAstV is classified into eight classical serotypes (HAstV 1–8) and two other divergent non-classical clades: Melbourne (MLB 1–3) and Virginia (VA 1–6), which have been associated with gastroenteritis, central nervous system complications, and acute respiratory disease. This study aimed to investigate the frequency of classical and non-classical HAstV in fecal specimens collected from children up to 14 years of age in northern Brazil, within the Amazon region, between 2013 and 2022. A total of 560 samples, all previously tested negative for other gastroenteric viruses such as rotavirus and norovirus, were analyzed using reverse transcription followed by quantitative polymerase chain reaction (RT-qPCR) and conventional RT-PCR. For classical HAstV, 10.7% (60/560) of the samples were positive by RT-qPCR and 2.0% (11/560) to 3.0% (17/560) by conventional RT-PCR using different primers set. Non-classical HAstV was detected in 0.2% (1/560) of the samples. Diarrhea was present in 91.7% of positive cases, vomiting in 71.7%, and fever in 53.3%. The most affected age group was children aged &gt;5–10 years (25.0%), with no significant association between infection rate and sex. A higher number of infections occurred during the Amazon winter (11.6%), with Roraima identified as the federative unit with the highest number of cases. Fifteen samples (88.2%, 15/17) were sequenced and identified as classical HAstV, with the following genotypes detected: HAstV-1 (60.0%, 9/15), HAstV-3 (20.0%, 3/15), and HAstV-4 (20.0%, 3/15). Non-classical HAstV sequencing was performed on 12 (93.2%, 12/13) positive specimens, characterized as HAstV-1 (50%, 6/12), HAstV-3 (25%, 3/12), HAstV-4 (16.7%, 2/12), and HAstV-MLB-3 (8.3%, 1/12). A probable recombinant strain was identified, classified as HAstV-4 based on the ORF2 region and HAstV-1 based on the ORF1b region. This study provides updated epidemiological data on HAstV in the Brazilian Amazon and highlights the genetic diversity of both classical and non-classical genotypes. Notably, it reports the first detection – and the second complete genome repository – of the rare MLB-3 genotype in the Americas.

Synergistic Dual Modulation of Li <sub>2</sub> S Redox Kinetics and Anode Stability Enabled by a High‐Efficiency Organodisulfide Mediator in Anode‐Free Lithium–Sulfur Batteries

Advanced Materials Kunlun Nie, Zhiwei Ni, Yuan Li et al. Jul 01, 2026 DOI: 10.1002/adma.73710

ABSTRACT Lithium sulfide (Li 2 S) is pivotal for high‐energy‐density lithium–sulfur (Li─S) batteries due to its high theoretical capacity, abundant sulfur resources, and compatibility with anode‐free architectures. However, its application is hindered by its intrinsically insulating nature and sluggish redox kinetics. Furthermore, traditional 1,3‐dioxolane/1,2‐dimethoxyethane electrolytes cannot withstand high voltages and pose safety hazards due to low flash points. Herein, we propose a synergistic strategy by introducing diisopropyl dithiocarbonate disulfide (DIP) as a multifunctional redox mediator into a high‐flash‐point, high‐voltage‐tolerant tetraethylene glycol dimethyl ether electrolyte system. DIP directly converts Li 2 S to lithium polysulfides, decreasing the activation voltage of the first charge to 2.48 from 3.18 V. Simultaneously, DIP facilitates the formation of an organosulfur‐rich solid electrolyte interface on the lithium surface, effectively suppressing lithium dendrite formation and growth. Crucially, this system enables stable cycling in anode‐free Cu||Li 2 S batteries for 160 cycles at 0.3 mAh cm −2 . Standard Li||Li 2 S cells also demonstrate superior durability, achieving an extremely low per‐cycle decay rate of 0.037% at 1C. Moreover, this strategy holds promise for other metal‐sulfur systems, such as Na─S, K─S, Ca─S, Mg─S, and Zn─S batteries, providing a feasible path for safe, next‐generation energy storage.

Oncogenic EGFR Mutants Differentially Alter Dimerization, Adaptor Protein Engagement, and Clathrin-Mediated Internalization

Journal of Biological Chemistry Maryam Bello-Hassan, Pradeep Kumar Singh, Adam W. Smith Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113353

Long-term neoadjuvant chemoradiotherapy combined with camrelizumab for locally advanced rectal cancer: A single-arm, prospective, phase II clinical study.

Journal of Clinical Oncology Chunbo Zhao, Qian Zhang, Li Li et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.93

93 Background: Neoadjuvant chemoradiotherapy (nCRT) has brought out a higher rate of complete response and anal sphincter preservation for locally advanced rectal cancer (LARC). Combining immunotherapy with radiotherapy and chemotherapy has shown synergistic effects. This study a evaluates the efficacy and safety of long-term nCRT with camrelizumab (a PD-1 inhibitor) for LARC and low rectal cancer requiring anal preservation. Methods: In this single-arm, prospective, phase II trial, patients with newly diagnosed LARC (cT3-4N0M0 or cT1-4N+M0) and low rectal cancer requiring sphincter preservation (cT2N0M0, &lt;5 cm from anal verge) were enrolled. All patients received long-course radiotherapy (50Gy/45Gy/25f) with concurrent chemotherapy [T2-3N0M0: capecitabine (1650 mg/m 2 /d, bid, d1-14, Q3W); T4N0M0 or T1-4N+M0: capecitabine + oxaliplatin (130 mg/m 2 , d1, Q3W)], plus camrelizumab (200 mg, d1, Q3W) for 4 cycles. Researchers evaluated patients after neoadjuvant therapy, followed by surgical resection. The primary endpoint was pathological complete response rate (pCR), and secondary endpoints included clinical complete response rate (cCR), objective response rate (ORR), disease control rate (DCR), disease-free survival, overall survival and safety. Results: Between January 2024 and December 2025, 58 patients were enrolled with 56 completing the efficacy evaluation. Among them, 2 patients achieved cCR, 22 patients had partial response, and 32 stable disease. The ORR was 42.9%, and DCR was 100%. Of 58 patients, 43 underwent surgery, 4 adopted wait and watch strategy (2 achieved cCR and 2 achieved near-cCR), 7 continued observation without surgery, 2 declined surgery, and 2 were in going therapy. All surgical patients achieved R0 resection, with pCR rate at 46.5% (20/43). Among the16 patients with low rectal cancer, 11 (68.8%) achieved anal sphincter preservation. In tumor regression grade (Mandard five-grade standard), 20 patients were Grade 1, 16 with Grade 2, 5 with Grade 3, and 2 with Grade 4. Regarding safety, 56 patients (100%) experienced treatment-related adverse effects, including lymphopenia (89.3%), reactive capillary endothelial proliferation (67.9%), leukopenia (39.3%), thrombocytopenia (33.9%), diarrhea (21.4%), fatigue (14.3%), and nausea (8.9%). Four patients reported Grade 3 adverse effects, predominantly lymphopenia (3.6%) and thrombocytopenia (3.6%). Patients generally tolerated treatment well, with symptoms managed and relieved symptomatically. Conclusions: Long-term neoadjuvant chemoradiotherapy (nCRT) with camrelizumab has shown promising rates of pathological complete response and clinical safety in patients with locally advanced and low rectal cancer aiming to preserve anal function. This ongoing study anticipates final results that may further enhance survival outcomes for these patients. Clinical trial information: NCT06304545 .

Metadynamics and Raman Spectroscopy for Glycan Structure–Spectrum Mapping

Journal of the American Chemical Society Varun Dolia, Nicholas Siemons, Jack Hu et al. Jul 01, 2026 DOI: 10.1021/jacs.6c01687

Real-world outcomes of Finerenone in patients with diabetic kidney disease in Saudi Arabia

PLoS ONE Mohamed A. Albekery, Ibrahim S. Alhomoud, Khalid A. Alamer et al. Jul 01, 2026 DOI: 10.1371/journal.pone.0352861

Background Diabetic kidney disease (DKD) represents a significant microvascular complication associated with type 2 diabetes mellitus (T2DM), markedly elevating the risk of kidney failure, cardiovascular events, and premature mortality. Despite advancements in therapeutic management, such as renin–angiotensin–aldosterone system (RAAS) blockade and sodium–glucose cotransporter 2 (SGLT2) inhibitors, residual risk remains significant. Finerenone, a novel nonsteroidal and selective mineralocorticoid receptor antagonist (MRA), has demonstrated substantial cardiorenal benefits in clinical trials; however, real-world data, especially from Saudi Arabia, remain limited. Method This single-center, retrospective cohort study. All adult patients (≥18 years) who received finerenone as part of routine clinical care were eligible if they met either of the following criteria: (1) documented diabetic kidney disease (DKD) based on KDIGO-aligned clinical criteria, including diabetes mellitus with chronic kidney disease manifested by albuminuria/proteinuria and/or reduced eGFR; (2) and/or a urine protein-to-creatinine ratio (uPCR) &gt;0.3 mg/mg. Longitudinal changes in uPCR, eGFR, and serum potassium were analyzed using linear mixed-effects models adjusted for relevant clinical covariates. Results A total of 75 patients prescribed finerenone were screened, of whom 67 met the inclusion criteria. The median age was 63 years, and 53.7% were female. Comorbidities were highly prevalent, including diabetes mellitus (89.6%), hypertension (97.0%), dyslipidemia (92.5%), heart failure (56.8%), and coronary artery disease (40.3%). A significant effect of time on uPCR was observed (F[3,193] = 3.457; P = 0.018), with a mean reduction of 0.464 mg/mg after six months (95% CI, −0.895 to −0.034; P = 0.027). The estimated eGFR slope after finerenone initiation was −1.08 mL/min/1.73 m² per month (95% CI −1.74 to −0.41; P = 0.002), corresponding to an annualized decline of approximately −12.9 mL/min/1.73 m² per year. Serum potassium increased modestly at early follow-up points (F[5,245] = 4.008; P = 0.002), rising by +0.209, + 0.256, and +0.286 mmol/L at the first three readings (P = 0.029, 0.005, and 0.006, respectively), then plateaued thereafter (P &gt; 0.5). Conclusion Finerenone use among DKD patients in Saudi Arabia was associated with significant reductions in proteinuria, an early decline in eGFR that requires cautious interpretation, and an overall favorable safety profile. These real-world findings align with results from pivotal clinical trials and support the incorporation of finerenone into standard DKD management. Future multicenter prospective studies are warranted to confirm these outcomes and evaluate long-term cardiorenal benefits.

Amphibious Breathable Ionic Skin Enabled by Dynamically Interlocked Star‐Shaped Ionic Liquid Telomers

Advanced Materials Wei Wang, Baohu Wu, Shengtong Sun et al. Jul 01, 2026 DOI: 10.1002/adma.73701

ABSTRACT Epidermal ionic skins act as promising adaptable interfaces for bioelectronics, but they often struggle to simultaneously maintain softness, breathability, adhesion, and conductivity across both dry and aquatic environments. Here, we introduce an amphibious ionic skin engineered by integrating a hydrophobic star‐shaped ionic liquid telomer as a bulky solvent within an amphiphilic linear poly(ionic liquid) network. The viscous four‐arm telomers are dynamically interlocked within the entangled matrix, facilitating robust water‐resistant self‐adhesion and self‐compliance. Meanwhile, the amphiphilic network provides efficient water‐permeable channels, ensuring superior moisture breathability in ambient conditions. Compared to conventional small‐molecule‐based ionic gels, our ionic skin exhibits high underwater stability due to the restricted leaching of the bulky telomeric species. When fabricated into ultrathin film electrodes, the material enables the acquisition of high‐fidelity electrophysiological signals in diverse environments, ranging from dry skin to fully submerged states. This topological network design provides a new strategy for developing environment‐adaptive skin‐like iontronic devices.

The Ion channel, CFTR, assembles with HIPPO pathway proteins TAZ and YAP in polycystic kidney disease

Journal of Biological Chemistry Abhishek Sharma, Masoud Afshani, Cristian Ciobanu et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113152

MicroRNA-197-3p to counteract chemoresistance in ovarian cancer via COL4A6 inhibition.

Journal of Clinical Oncology Yi-Hui Wu Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.221

221 Background: Collagen type IV alpha 6 (COL4A6) is overexpressed in ovarian cancer, where its elevated levels contribute to tumor progression, chemoresistance, and poor clinical outcomes. Although dysregulation of microRNAs (miRNAs) is well documented in epithelial ovarian carcinoma (EOC), whether they contribute to the control of COL4A6 expression has not been clearly established. Methods: miR-197-3p levels in EOC tissues and cell lines were measured using real-time PCR. Functional experiments, including assays for cell viability and cisplatin responsiveness, were conducted to determine the biological role of miR-197-3p in ovarian cancer cells. Candidate genes regulated by miR-197-3p were examined and confirmed through luciferase reporter testing together with protein-level verification by western blotting. Associations between miR-197-3p expression and clinical outcomes were subsequently examined. Results: miR-197-3p expression was markedly reduced in both EOC tissues and cell lines. Restoring miR-197-3p levels suppressed ovarian cancer cell viability and increased their responsiveness to cisplatin. Mechanistic studies demonstrated that miR-197-3p directly targets COL4A6, and modification of this regulatory axis alters cellular survival and chemoresistance. Clinically, diminished miR-197-3p expression correlated with advanced disease stage, suboptimal chemotherapy response, earlier recurrence, and poorer overall and progression-free survival. Conclusions: miR-197-3p inhibits EOC progression and reduces chemoresistance by directly targeting COL4A6, underscoring its promise as a potential therapeutic candidate.